Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte 6% versus Ionolyte in trauma patients with hypovolaemia
NL-OMON50632Phase 4Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hetastarch and Ionolyte in hypovolemia, sponsored by PRA Health Sciences. Started Sep 2017; status: active, not recruiting.
02
Drugs
hetastarchIonolyte
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NL-OMON50632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50632.